Detalhe da pesquisa
1.
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines.
Cell
; 184(21): 5432-5447.e16, 2021 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34619077
2.
Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responses.
Immunity
; 55(9): 1680-1692.e8, 2022 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35977542
3.
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice.
Cell Rep
; 40(9): 111299, 2022 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35988541
4.
Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogens.
Cell Rep Med
; 3(10): 100780, 2022 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36206752
5.
Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.
Front Immunol
; 12: 710263, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34267764
6.
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines.
bioRxiv
; 2021 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33758839